Generics 49

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Pemetrexed manufacturers

49 products found

Filters

49 products found

pemetrexed

Vials 100 mg, 500 mg, 1000 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
MAs for sale
Austria , France , Ireland , Italy , Netherlands
Manufacturer #276

Manufacturer usually replies in 1 days

pemetrexed

Vials, lyophilized injection 100 mg, 500 mg, 1000 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
MAs for sale
Netherlands
Manufacturer #276

Manufacturer usually replies in 1 days

pemetrexed

Concentrate for solution for infusion 100 mg/4 ml, 500 mg/20 ml, 1000 mg/40 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #12922

Manufacturer usually replies in 7 days

pemetrexed

Vials, injection 100mg/10ml, 500mg/50ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #651

Manufacturer usually replies in 6 days

pemetrexed

Vials, injection 100, 500mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
United Arab Emirates , Oman , Qatar , Bahrain , Kuwait , Vietnam
Manufacturer #12186
The activity of the company is based on the development of highly competitive processes for the manufacture of active ingredients with high added value that meet the strictest quality specifications. They manufacture under strict compliance with the environmental and occupational safety regulations in force in Europe. They focus on the pharmaceutical, hospital, diagnostic, fine chemical, and food fields. Its products are marketed in more than 70 countries.

Manufacturer usually replies in 7 days

pemetrexed

Powder for solution for infusion 100 mg, 500 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Serbia , Vietnam
Available for
Licensing with supply, Technology transfer
MAs for sale
Germany , Portugal , Spain , United Kingdom
Manufacturer #12180
It is a pharmaceutical company focused on discovering, licensing, and manufacturing generics and added-value medications that meet stringent quality standards set by the FDA and the EMA. They design and produce in accordance with European quality standards. They have over 30 years of experience and have completed over 30 licensing agreements around the world.

Manufacturer usually replies in 6 days

pemetrexed

Solution for injection 100 mg, 500 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #609

A pharmaceutical manufacturer based in Europe that has been active in 60+ countries selling its products in Europe, North America, LATAM, and MENA for 10+ years. The key production line is Rx. Main dosage forms include injectable and oral liquid. The company's production lines are EU GMP-compliant.

Manufacturer usually replies in 6 days

pemetrexed

Powder and solvent for solution for infusion 100mg, 500mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Registered in
Germany
Available for
Licensing with supply, Distribution only
Manufacturer #16717
They've been serving and assisting customers in the healthcare business in Regulatory Affairs and Pharmacovigilance for over 30 years. This sphere of action covers many countries around the world. They look after their local and European consumers and the supply chain by providing high-quality products for internationalization strategies.

Manufacturer usually replies in 14 days

pemetrexed

Vials, lyophilized injection 100 mg, 500 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #17047
A pharmaceutical manufacturer based in the EU that sells its products in Europe, the Middle East, CIS, LATAM, and Asia. Key production lines are pharmaceuticals, bio and nanopharmaceuticals, medical devices, and nutraceuticals. The main therapeutic area is oncology.

Manufacturer usually replies in 10 days

pemetrexed

Vials, injection 100mg/vial 500mg/vial

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
EU GMP
Unavailable markets
United Kingdom
Manufacturer #9300

Manufacturer usually replies in 3 days

pemetrexed

Vials, injection 100 mg, 500 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
Costa Rica
Registered in
Austria , Belgium , Czech Republic , Estonia , France , Germany , Italy , Malta , Netherlands , Romania , Spain , United Kingdom
Manufacturer #1338

Manufacturer usually replies in 7 days

pemetrexed

Vials, injection 100mg, 500mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
EU GMP, ANVISA
Unavailable markets
Saudi Arabia , United Arab Emirates , Qatar , Bahrain , Kuwait , Oman , Egypt
Available for
Licensing with supply, Distribution only
Manufacturer #11475
The company is situated in South America and over time has expanded producing oncology drugs for Latin America, Asia Pacific, Europe, and North America, including the United States. The goal of the company is to develop and produce high-quality oncology generics and generics with value-added technology or super generics. Part of the goal is also to produce efficient processes that allow us to have competitive prices.

Manufacturer usually replies in 4 days

pemetrexed

Solution for injection 10 mg/ml , 100 mg, 500 mg, 1000 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
Costa Rica
Manufacturer #1338

Manufacturer usually replies in 7 days

pemetrexed

Vials, injection 100 mg, 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Available for
Licensing with supply, Distribution only
Manufacturer #17708

Manufacturer usually replies in 4 days

pemetrexed

Solution for injection 100mg, 500mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
EU GMP
Manufacturer #1026

Manufacturer usually replies in 4 days

pemetrexed

Injection, lyophilized 500 mg - 50 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP, PICS
Manufacturer #2760

Manufacturer usually replies in 5 days

pemetrexed

Vials, lyophilized injection 100 mg/4 ml, 500 mg/20 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP
Manufacturer #2722
It originally entered the pharmaceutical industry in 1987, when it introduced blood derivative products to Europe and became the exclusive distributor for prominent European brands. Oncology, hematology, dermatology, radiology, rheumatology, immunology, and OTC products are the seven main therapeutic fields.

Manufacturer usually replies in 6 days

pemetrexed

Solution for injection 100mg, 500mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, WHO
Manufacturer #9406

Manufacturer usually replies in 7 days

pemetrexed

Injection 100 mg , 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #22283

Manufacturer usually replies in 4 days

pemetrexed

Solution for infusion 100 mg, 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
PICS
Manufacturer #21567

Manufacturer usually replies in 2 days

Want to view all 49 products? Create your free account today!

Pemetrexed Manufacturers

Pemetrexed is a chemotherapy medication used to treat malignant pleural mesothelioma and non-small cell lung cancer. When surgery is not an option, pemetrexed injection is frequently used in conjunction with another chemotherapeutic drug as a first line treatment for malignant pleural mesothelioma. The drug pemetrexed belongs to a group of drugs known as antifolate antineoplastic agents. Suppliers of pemetrexed market it as concentrates as well as lyophilized powders for intravenous infusion. The clinical developer and earliest manufacturer of pemetrexed is Eli Lilly, who first introduced the drug in 2004 under the trade name Alimta. Alimta was granted FDA approval for the treatment of tumors of the mesothelium in 2004, and the treatment of non-small lung cancer in 2008. The patent for pemetrexed expired in Europe and Japan in 2015 and in the U.S. in 2017. Although manufacturer Eli Lily managed to stave off market entry from competitors in the U.S. until 2020, other manufacturers of pemetrexed have introduced generic variants of the drug across other geographic markets. Such companies include Pfizer, Glenmark, STADA Arzneimittel, Teva, and Novartis. Also, pemetrexed and pembrolizumab, a drug marketed by major U.S. manufacturer Merck & Co. under the trade name Keytruda, are clinically proven to complement each other in oncological treatment. FDA has termed the drug combination as the first-line treatment of non-small lung cancer.

How Does Pemetrexed Work?

It functions by preventing a certain chemical from acting in the body in a way that might promote the growth of cancer cells. Pemetrexed, an antifolate with pyrrolopyrimidine-based nucleus, inhibits folate-dependent metabolic processes necessary for cell replication in order to exert its anticancer action. Pemetrexed suppresses all folate-dependent enzymes are involved in the de novo production of thymidine and purine nucleotides, including thymidylate synthase, dihydrofolate dehydrogenase, and glycinamide ribonucleotide formyltransferase, according to in vitro studies. Both the membrane folate interacting protein transport mechanism and the decreased folate carrier are used to deliver pemetrexed into cells. The molecule folylpolyglutamate synthetase transforms pemetrexed into polyglutamate forms once it has entered the cell. The polyglutamate forms, which inhibit TS and GARFT, are kept in cells. In tumour cells and, to a lesser extent, in normal tissues, polyglutamation is a time- and concentration-dependent process.

Wholesale Price of Pemetrexed

Pemetrexed is a costly drug. Retail prices per 500mg of Alimta intravenous powder fall into an approximate range of 1000 EUR to 1600 EUR. Explore the offers of Pemetrexed from vendors on our pharmaceutical marketplace or to look up more essential online information about Pemetrexed. The price of Pemetrexed is higher than that of such substitutes, owing largely to the more costly manufacturing process needed to produce it. Also, the costs of Pemetrexed vary depending on manufacturer and supplier pricing, whether it is a generic or trade name formulation, concentration of the active ingredient in the formulation. It is available or sale at every medical store. Pemetrexed suppliers, on the whole, are in favor of patient aid initiatives. Pemetrexed is available for sale from various Pemetrexed vendors at multiple costs.

From Where to Get Pemetrexed?

Pharmaceutical specialists are welcome to browse through offers of Pemetrexed capsules, injectable solutions, and oral solutions from suppliers in our B2B pharmaceutical marketplace, or else find more information about Pemetrexed online at the official Epilepsy Foundation website. Making use of Pipelinepharma's worldwide B2B online marketplace for medications and other pharmaceuticals is the ideal approach to locate and acquire access to Pemetrexed manufacturers and suppliers. Finding reliable suppliers and manufacturers of particular medications like Pemetrexed can typically be a time-consuming challenge, but with Pipelinepharma's straightforward search engine and network of tested partners, the entire process becomes much simpler. Utilizing our built-in search engine, all you have to do to begin going is start looking for potential Pemetrexed suppliers or manufacturers. You may also use filters to narrow down your search results and look for Pemetrexed from particular nations.

Navigating our Pharmaceutical Marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Pemetrexed offerings can be narrowed down with filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for this substance manufacturer and Pemetrexed suppliers that you are looking for. These also enable you to check the dossier status of this medicine and the GMP approvals of the different variants of Pemetrexed. Also, each manufacturer or supplier product description contains essential information about this substance, including clinical data, stability zones, and countries in which Pemetrexed is already registered. Manufacturers also have special delivery terms.

Establishing Commercial Ties

Suppose you are a pharmaceutical licensing company or a distributor. In that case, you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and order process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the Pemetrexed suppliers. This way, the marketplace allows you as a distributor to skip the process of making a list of product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are boarded on the platform. This allows us to screen Pemetrexed manufacturers for the quality of the pharmaceutical products' dossiers and protect against the risk of possible malpractices.